Pharmaceutical Science Update

November 15, 2017

India's Lupin Gets FDA Warning for Two Pharma Facilities

Indian drugmaker Lupin Ltd. received a warning letter from the food and Drug Administration (FDA) for two of its manufacturing facilities and said new product approvals may be delayed due to the letter.